Baidu
map

工商总局回应“假神医”:加强医药、保健品等广告监管

2017-07-14 佚名 中新经纬

工商总局将进一步加强医疗、药品、保健食品等重点广告监管执法,依法严肃查处虚假违法广告,涉嫌犯罪的,坚决移送司法机关。


7月13日,国家工商总局召开例行新闻发布会。针对媒体关于假医药专家刘洪斌的提问,国家工商行政管理总局办公厅主任、新闻发言人于法昌称,下一步,工商总局将进一步加强医疗、药品、保健食品等重点广告监管执法,强化对各地案件查处工作的督导指挥,依法严肃查处虚假违法广告,涉嫌犯罪的,坚决移送司法机关。

于法昌在发布会中称,近期,有关媒体报道“医药广告表演者”事件后,工商总局高度重视,局长张茅同志、副局长甘霖同志明确要求迅速行动,采取有力措施,依法严肃查处。各级工商和市场监管部门按照总局统一部署,快速反应,立即行动,迅速开展了执法检查。工商总局主要采取了四项措施:

一是专题部署,明确工作要求。工商总局召开全国工商和市场监管部门专项案件查办工作视频指挥调度会议,部署各地工商和市场监管部门立即行动,严肃查处,及时回应社会关切。工商总局明确要求各地加大执法力度,从严从快查处虚假违法广告,对涉嫌构成犯罪的,要及时移送公安机关。

二是在6月23号媒体报道之后,总局迅速通过官方网站回应了社会关切,表明了总局坚决查处违法广告、维护广大消费者合法权益的信心和决心。

三是加强协同监管,形成监管合力。工商总局充分发挥整治虚假违法广告部际联席会议机制作用,已与新闻出版广电总局、食品药品监管总局、卫生计生委、中医药管理局、公安部等成员单位专题研究,各部门将依据各自职能依法调查处理。各部门及时通报案件信息,形成监管执法合力。

四是开展专项监测,加大查处力度。工商总局立即组织开展了专项监测,及时下发监测数据,要求各地迅速采取措施,依法处理。各地加大执法力度,依法查处涉案广告主、广告经营者、广告发布者、广告代言人。

于法昌称,2015年以来各地工商和市场监管部门共作出责令整改通知136件,办结案件76件,处罚款283万余元,作出行政处罚的地区涉及到20个省(市、自治区)。目前,已有41件案件各地正在调查处理,还有多个案件正在立案调查中。

他表示,下一步,工商总局将进一步加强医疗、药品、保健食品等重点广告监管执法,强化对各地案件查处工作的督导指挥,依法严肃查处虚假违法广告,涉嫌犯罪的,坚决移送司法机关。同时,会同相关主管部门研究加强对健康养生类栏目及广告的监管措施。近期,工商总局将陆续公布各地查处虚假违法广告的典型案例,回应社会关切。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1371472, encodeId=df5e13e147224, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408989, encodeId=33611408989b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222203, encodeId=3dac22220304, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Jul 14 11:23:51 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222183, encodeId=12652221832e, content=不错 内容很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5DSGKABL9712Y3VJgXU8LVOiaz3fJ5qYw34DuokV4VW7xkY4WwDcXSzicOV77eC5ofpy9E5M6eiac2UkLicibvnfC7n/0, createdBy=04de1734630, createdName=1def675cm03(暂无匿称), createdTime=Fri Jul 14 10:47:49 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-16 wwzzly
  2. [GetPortalCommentsPageByObjectIdResponse(id=1371472, encodeId=df5e13e147224, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408989, encodeId=33611408989b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222203, encodeId=3dac22220304, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Jul 14 11:23:51 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222183, encodeId=12652221832e, content=不错 内容很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5DSGKABL9712Y3VJgXU8LVOiaz3fJ5qYw34DuokV4VW7xkY4WwDcXSzicOV77eC5ofpy9E5M6eiac2UkLicibvnfC7n/0, createdBy=04de1734630, createdName=1def675cm03(暂无匿称), createdTime=Fri Jul 14 10:47:49 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-16 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1371472, encodeId=df5e13e147224, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408989, encodeId=33611408989b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222203, encodeId=3dac22220304, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Jul 14 11:23:51 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222183, encodeId=12652221832e, content=不错 内容很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5DSGKABL9712Y3VJgXU8LVOiaz3fJ5qYw34DuokV4VW7xkY4WwDcXSzicOV77eC5ofpy9E5M6eiac2UkLicibvnfC7n/0, createdBy=04de1734630, createdName=1def675cm03(暂无匿称), createdTime=Fri Jul 14 10:47:49 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-14 139****5926

    好好文章学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1371472, encodeId=df5e13e147224, content=<a href='/topic/show?id=bf1ce2339d0' target=_blank style='color:#2F92EE;'>#监管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72339, encryptionId=bf1ce2339d0, topicName=监管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408989, encodeId=33611408989b6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jul 16 01:42:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222203, encodeId=3dac22220304, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Fri Jul 14 11:23:51 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222183, encodeId=12652221832e, content=不错 内容很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5DSGKABL9712Y3VJgXU8LVOiaz3fJ5qYw34DuokV4VW7xkY4WwDcXSzicOV77eC5ofpy9E5M6eiac2UkLicibvnfC7n/0, createdBy=04de1734630, createdName=1def675cm03(暂无匿称), createdTime=Fri Jul 14 10:47:49 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-14 1def675cm03(暂无匿称)

    不错 内容很有用

    0

Baidu
map
Baidu
map
Baidu
map